Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Greg Rich who wrote (2732)	10/12/1999 1:30:00 AM
From: Edscharp	Respond to of 4676

I'm going to go way out on a limb on this one. I just read this article that Millenium Pharmaceuticals (MLMN) is looking to make an acquisition before the end of this year. Message 11509602 I'm going to predict they go after Isis Pharmacy. This is 100% sheer conjecture on my part and I don't blame anybody for thinking me a raving madman, but I believe it would be the perfect marriage. Millenium has a huge data base of genomic information, but lacks the technology to develop their discoveries into drugs. Isis, with a proven antisense technology, would create a powerhouse bio-pharmaceutical. Alright, I'll retract my prediction, but I'll still keep it on my wish list.

To: Greg Rich who wrote (2732)	10/12/1999 10:16:00 AM
From: Scott H. Davis	Read Replies (1) \| Respond to of 4676

I'm sometimes too slow afoot. Nearly bought IMCL on the major dip, as I have some cash (took some profits elsewhere and am resisting compulsion to be fully invested) Also, regarding comments about Jim M. In all fairness, a lot of people were premature on ISIP, including many of us. Partially because the non participation of biotechs in the market increases the last few years in the face of great news blew a lot of our circuits. Partially this may have been the result of hyping questionable science on the part of some other biotechs & some poor management - bad apples spoiling the bushell caused some folks to take an "I'll believe it when I see some results" mindset. Looks like the approvals the last couple years and the number of promising things in PIII is causing a re-assessment of the sector. IMSCO Scott Also, JM was very right on with IMCL in Worth last fall.

To: Greg Rich who wrote (2732)	10/12/1999 10:56:00 AM
From: tuck	Respond to of 4676

Greg, Your welcome, though it doesn't look like it helped you much. My prognostications have gotten a lot better this year, I've only picked one obvious lemon so far. That simply means the law of averages is catching up with me in a positive way. It also means that I am now full time as an investor and able to be nimble when nimbleness is required. I've followed ISIP loosely for some years, and talked my Mom into buying a little a couple of years ago at these prices. So I've some idea of its trading patterns and what drives it, but I'm still doing some catch up reading. I live about half an hour from ISIP, and maybe I'll go visit soon, and ask what they're up to with all this construction. If you bought IMCL on this freak dip, you were pretty sharp for a part time trader. One's past DD on the patent estate was required to courageously buy or hold in the face of the drop, because it would have taken too long to do it while it was happening. I also bought on the dip, at 22. I was in it this spring, but I hedged with calls (which is my usual M.O.) and got exercised. IMCL had not looked back since, till a few days ago. It sounds like you managed to catch a good chunk of IMCL's rebound, so things turned out OK. I expect ISIP will give some back in next few days, which is why I hedged half my position, and which may allow you to get back in. This depends, of course, on how close the actual news -- rumors of which have driven the stock -- is. And who knows? So it's hard to give a price target for reentry. In your shoes, I'd try to average in below 13. If it never gets there, well, at least I'm happy that the remainder of the position is doing well. Cheers, Tuck